Ayrton Capital LLC 13D and 13G filings for SUNESIS PHARMACEUTICALS INC CO:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 11:06 am Sale |
2020-12-31 | 13G | SUNESIS PHARMACEUTICALS INC CO SNSS |
Ayrton Capital LLC | 0 0.000% |
-10,869,565 (Position Closed) |
Filing |
| 2020-08-07 2:51 pm Purchase |
2020-07-29 | 13G | SUNESIS PHARMACEUTICALS INC CO SNSS |
Ayrton Capital LLC | 10,869,565 6.650% |
10,869,565 (New Position) |
Filing |